| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8615332 | Clinical Lymphoma Myeloma and Leukemia | 2018 | 36 Pages |
Abstract
Our study has shown that bortezomib-based therapy before ASCT improves the hematologic response, organ response and overall survival, potentially by decreasing the light chain load before ASCT.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Tania Jain, Heidi E. Kosiorek, Shu T. Kung, Vishal S. Shah, Amylou C. Dueck, Veronica Gonzalez-Calle, Susan Luft, Craig B. Reeder, Roberta Adams, Pierre Noel, Jeremy T. Larsen, Joseph Mikhael, Leif Bergsagel, A. Keith Stewart, Rafael Fonseca,